Dr. Bonacini pursues clinical research in liver fibrosis, drug-induced liver injury, hepatitis B and C therapy, and clostridium difficile infection after liver transplants. He is a principal investigator on studies investigating the influence of HIV infection on chronic hepatitis B and C infection, efficacy and safety of new therapies for hepatitis B and C, and hepatitis C persistence and pathogenesis. Dr. Bonacini’s research has been published in peer-reviewed journals including The American Journal of Gastroenterology, Hepatology, Gastroenterology, Archives of Internal Medicine, and The American Journal of Medicine.
Sutter Health Research Enterprise
St. Luke's Hospital 1580 Valencia Street Suite 8
San Francisco, CA, 94110